Keyphrases
Antiphospholipid Antibodies
100%
COVID-19
100%
Convalescent Plasma
100%
Mild COVID-19 Infection
100%
Lupus Anticoagulant
62%
Glycoprotein
37%
Silica Clotting Time
37%
Dilute Russell's Viper Venom Time
25%
Disease Severity
12%
High Prevalence
12%
Low Prevalence
12%
Healthy Donors
12%
Passive Immunization
12%
Thrombosis Risk
12%
Severe COVID-19
12%
COVID-19 Patients
12%
Patients with COVID-19
12%
Mild COVID-19
12%
COVID-19 Convalescent Plasma
12%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Antiphospholipid Antibody
100%
Lupus Anticoagulant
83%
Prevalence
66%
Glycoprotein
50%
Silicon Dioxide
50%
Clotting Time
50%
Viper Venom
33%
Daboia russellii
33%
Normal Human
16%
Thrombosis
16%
SARS Coronavirus
16%
Immunoglobulin M
16%
Diseases
16%
Immunology and Microbiology
Blood Plasma
100%
COVID-19
100%
Antiphospholipid Antibody
100%
Lupus Anticoagulant
38%
Prevalence
30%
Glycoprotein
23%
Clotting Time
23%
Daboia russellii
15%
Normal Human
7%
Immunoglobulin M
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%